2m 2m 2m 2m 2m 2m 2m
10X GENOMICS-A (TXG)
NASDAQ
$42.19+$0.42 (+1.01%)
Price as of Jul 14, 2026 5:45 AM EDT- $4.9BMarket Cap
- 234.96%1-Year Change
- Health Information ServicesIndustry
10X GENOMICS-A (TXG)
$42.19+$0.42 (+1.01%)
TXG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.77 | ||
Change | -$0.96 (-2.25%) | ||
Open | $42.66 | ||
High | $43.98 | ||
Low | $41.60 | ||
Previous Close | $42.73 | ||
Volume | 2,497,014 | ||
30-Day Average Volume | 3,473,103 | ||
1-Week Change | 4.43% | ||
1-Month Change | 44.83% | ||
1-Year Change | 234.96% | ||
3-Year Change | -27.51% | ||
5-Year Change | -76.96% | ||
Fundamentals | |||
Shares Outstanding | 116.9M | ||
Total Assets | $1.0B | ||
Market Cap | $4.9B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $149.9M | ||
Net Income | -$13.5M | ||
Free Cash Flow | $24.5M | ||
EBIT | -$12.8M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $556.1M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -1,520 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 6 | ||
P/E | -418 | ||
PEG | -19 | ||
Price/Free Cash Flow | 199 | ||
Price/Operating Cash Flow | 187 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue